s6y
Company name or ticker
Search
Biomea Fusion, Inc.
4
A2A Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Monday, July 25, 2022
Period
Jul 21, 2022
Accession number
0001859061-22-000001
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header